About 6 in 10 people say they probably won’t get an updated shot this year, despite the CDC’s recommendation that everyone do so, according to results of a new survey from the Pew Research Center.
More than half of U.S. adults now qualify to take semaglutide, the popular diabetes and weight loss drug sold under the brand names Ozempic and Wegovy.
The critical key to weight loss success? Sustainability. No single diet or plan works for everybody, but a secret formula does exist – and it’s unique to you.
The FDA has approved a new drug called revumenib that can be taken orally to treat acute leukemia in patients 1 year or older. The drug will be marketed under the brand name Revuforj.
The FDA has granted fast-track approval for a groundbreaking gene therapy indicated for a rare genetic disorder called ...
In the U.S., the least active 25% of the population over 40 could add 11 years to their average life expectancy if they were ...
New data shows that men are still more likely than women to be diagnosed with diabetes in the U.S., rates of the disease have ...
More research shows that your ability to balance on one leg can reveal how well you’re aging. Discover the fascinating science for why, and what you can do to improve.
People whose choice of alcoholic beverage is exclusively beer tend to have particularly poor diets. They also are more likely ...
Olenick recommends about 1 gram of protein per pound of ideal body weight throughout the day, along with heavy (7-9 effort) ...
As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new ...
With your doctor’s recommendation, exploring yoga as a remedy for low back pain is now easier than ever – giving you the ...